Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sarah A. Mansfield"'
Autor:
Isa F. Ashoor, Sarah A. Mansfield, Michelle M. O'Shaughnessy, Rulan S. Parekh, Jarcy Zee, Tetyana L. Vasylyeva, Amy J. Kogon, Christine B. Sethna, Dorey A. Glenn, Aftab S. Chishti, Donald J. Weaver, Margaret E. Helmuth, Hilda E. Fernandez, Michelle N. Rheault
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 14 (2019)
Background Cardiovascular disease is a major cause of morbidity and mortality in children with chronic kidney disease. We sought to determine the prevalence of cardiovascular risk factors in children with glomerular disease and to describe current pr
Externí odkaz:
https://doaj.org/article/3f407ad16004479aab6afe10a0479237
Autor:
Ziya Kirkali, Pooja Talaty, Catherine S. Bradley, David Cella, Kathryn E. Flynn, Brenda W. Gillespie, Margaret E. Helmuth, Abigail R. Smith, James W. Griffith, H. Henry Lai, Sarah A. Mansfield, Kevin P. Weinfurt
Publikováno v:
Neurourol Urodyn
Aims Measurement of self-reported lower urinary tract symptoms (LUTS) typically uses a recall period, for example, "In the past 30 days…." Compared to averaged daily reports, 30-day recall is generally unbiased, but recall bias varies by item. We e
Autor:
J. Quentin Clemens, Matthew O. Fraser, Michelle Taddeo, Alexander P. Glaser, Victor P. Andreev, Brad Erickson, Ziya Kirkali, Anne P. Cameron, Sarah A. Mansfield, Brian T. Helfand, James W. Griffith, Abigail R. Smith, Kathryn E. Flynn, Aruna V. Sarma, Claire C. Yang, H. Henry Lai
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Lower urinary tract symptoms (LUTS) are highly prevalent, decrease health-related quality of life (QOL), and are costly to treat. It is useful to consider storage symptom...
Autor:
Sarah A. Mansfield, Yichun Hu, Michelle M. O’Shaughnessy, Susan L. Hogan, Jarcy Zee, Ronald Falk, Andrew S. Bomback, Dorey A. Glenn, Michelle R. Denburg, Candace D. Henderson, Anisha Hegde, Laura H. Mariani, Keisha L. Gibson, Larry A. Greenbaum, Amy K. Mottl
Publikováno v:
Kidney International Reports
Autor:
Catherine S. Bradley, Kevin P. Weinfurt, David Cella, H. Henry Lai, Sarah A. Mansfield, James Quentin Clemens, Brenda W. Gillespie, Kathryn E. Flynn, Abigail R. Smith, Margaret E. Helmuth, Pooja Talaty, Ziya Kirkali
Publikováno v:
Journal of Urology. 202:770-778
Self-reported measurement tools often provide a recall period, eg "In the past 7 days…" For lower urinary tract symptoms the concordance of end of day (daily) reports with 7 and 30-day recalled reports is unknown to our knowledge. We evaluated how
Autor:
Margaret E. Helmuth, David Cella, H. Henry Lai, Brenda W. Gillespie, Kevin P. Weinfurt, Abigail R. Smith, Sarah A. Mansfield, Kathryn E. Flynn, Catherine S. Bradley, Pooja Talaty, Ziya Kirkali
Publikováno v:
Journal of Urology. 203
Autor:
Sarah A. Mansfield, Christine B. Sethna, Michelle N. Rheault, Amy J. Kogon, Michelle M. O’Shaughnessy, Margaret E. Helmuth, Hilda Fernandez, Tetyana L. Vasylyeva, Jarcy Zee, Isa F. Ashoor, Dorey A. Glenn, Rulan S. Parekh, Aftab S. Chishti, Donald J. Weaver
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Cardiovascular disease is a major cause of morbidity and mortality in children with chronic kidney disease. We sought to determine the prevalence of cardiovascular risk factors in children with glomerular disease and to describe current pr
Autor:
Ziya Kirkali, Pooja Talaty, Sarah A. Mansfield, Brenda W. Gillespie, Kevin P. Weinfurt, Catherine S. Bradley, J. Quentin Clemens, Kathryn E. Flynn, H. Henry Lai, Abigail R. Smith, Margaret E. Helmuth
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Self-reported measurement tools often refer to a time period over which respondents are asked to recall their experience, e.g., “In the past 7 days...&” However, there i...
RATIONALE & OBJECTIVE: The standard method to calculate time to the event of a specified percentage decline in estimated glomerular filtration rate (eGFR) uses two eGFR assessments, one at baseline and one at the event time. However, event times may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c346c78f9f43896e5f2bca115770c769
https://europepmc.org/articles/PMC6309673/
https://europepmc.org/articles/PMC6309673/
Autor:
David T. Selewski, Josephine M. Ambruzs, Gerald B. Appel, Andrew S. Bomback, Raed Bou Matar, Yi Cai, Daniel C. Cattran, Aftab S. Chishti, Vivette D. D'Agati, Cynthia J. D'Alessandri-Silva, Rasheed A. Gbadegesin, Jonathan J. Hogan, Sandra Iragorri, J. Charles Jennette, Bruce A. Julian, Myda Khalid, Richard A. Lafayette, Helen Liapis, Francesca Lugani, Sarah A. Mansfield, Sherene Mason, Patrick H. Nachman, Cynthia C. Nast, Carla M. Nester, Damien G. Noone, Jan Novak, Michelle M. O'Shaughnessy, Heather N. Reich, Michelle N. Rheault, Dana V. Rizk, Manish K. Saha, Neil S. Sanghani, C. John Sperati, Rajasree Sreedharan, Tarak Srivastava, Agnieszka Swiatecka-Urban, Katherine Twombley, Tetyana L. Vasylyeva, Donald J. Weaver, Hong Yin, Jarcy Zee, Ronald J. Falk, Ali G. Gharavi, Brenda W. Gillespie, Debbie S. Gipson, Larry A. Greenbaum, Lawrence B. Holzman, Matthias Kretzler, Bruce M. Robinson, William E. Smoyer, Michael Flessner, Lisa M. Guay-Woodford, Krzysztof Kiryluk, Ali Gharavi, Wooin Ahn, Rupali S. Avasare, Revekka Babayev, Ibrahim Batal, Eric Brown, Eric S. Campenot, Pietro Canetta, Brenda Chan, Vivette D. D’Agati, Hilda Fernandez, Bartosz Foroncewicz, Gian Marco Ghiggeri, William H. Hines, Namrata G. Jain, Fangming Lin, Maddalena Marasa, Glen Markowitz, Sumit Mohan, Krzysztof Mucha, Thomas L. Nickolas, Jai Radhakrishnan, Maya K. Rao, Renu Regunathan-Shenk, Simone Sanna-Cherchi, Dominick Santoriello, Michael B. Stokes, Natalie Yu, Anthony M. Valeri, Ronald Zviti, Amira Al-Uzri, Isa Ashoor, Diego Aviles, Rossana Baracco, John Barcia, Sharon Bartosh, Craig Belsha, Michael C. Braun, Aftab Chishti, Donna Claes, Carl Cramer, Keefe Davis, Elif Erkan, Daniel Feig, Michael Freundlich, Melisha Hanna, Guillermo Hidalgo, Amrish Jain, Mahmoud Kallash, Jerome C. Lane, John Mahan, Nisha Mathews, Carla Nester, Cynthia Pan, Hiren Patel, Adelaide Revell, Julia Steinke, Scott E. Wenderfer, Craig S. Wong, Ronald Falk, William Cook, Vimal Derebail, Agnes Fogo, Adil Gasim, Todd Gehr, Raymond Harris, Jason Kidd, Louis-Philippe Laurin, Will Pendergraft, Vincent Pichette, Thomas Brian Powell, Matthew B. Renfrow, Virginie Royal, Sharon Adler, Charles Alpers, Elizabeth Brown, Daniel Cattran, Michael Choi, Katherine M. Dell, Ram Dukkipati, Fernando C. Fervenza, Alessia Fornoni, Crystal Gadegbeku, Patrick Gipson, Leah Hasely, Sangeeta Hingorani, Michelle A. Hladunewich, Jonathan Hogan, J. Ashley Jefferson, Kenar Jhaveri, Duncan B. Johnstone, Frederick Kaskel, Amy Kogan, Jeffrey Kopp, Kevin V. Lemley, Laura Malaga- Dieguez, Kevin Meyers, Alicia Neu, Michelle Marie O’Shaughnessy, John F. O’Toole, Rulan Parekh, Heather Reich, Kimberly Reidy, Helbert Rondon, Kamalanathan K. Sambandam, John R. Sedor, Christine B. Sethna, Jeffrey Schelling, Agnes Swiatecka-Urban, Howard Trachtman, Katherine R. Tuttle, Joseph Weisstuch, Olga Zhdanova, Brenda Gillespie, Laura Barisoni, Sarah Mansfield, Laura Mariani, Matthew Wladkowski
Publikováno v:
Kidney International Reports
Introduction The Cure Glomerulonephropathy Network (CureGN) is a 66-center longitudinal observational study of patients with biopsy-confirmed minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, or IgA nephropathy (IgAN